Independent and interactive effects of plant sterols and fish oil n-3 long-chain polyunsaturated fatty acids on the plasma lipid profile of mildly hyperlipidaemic Indian adults

British Journal of Nutrition

Volumn 102, Issue 5, 2009, Pages 722-732

  Khandelwal, Shweta ^a   Demonty, Isabelle ^b   Jeemon, Panniyammakal ^a   Lakshmy, Ramakrishnan ^c   Mukherjee, Rajat ^d   Gupta, Ruby ^c   Snehi, Uma ^a   Niveditha, Devasenapathy ^a   Singh, Yogendra ^c   Van Der Knaap, Henk C M ^b   Passi, Santosh J ^e   Prabhakaran, Dorairaj ^a   Reddy, K Srinath ^d  

^a CENTRE FOR CHRONIC DISEASE CONTROL   (India)

^b UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^d PUBLIC HEALTH FOUNDATION OF INDIA   (India)

^e University of Delhi ^*  (India)

Author keywords

Fish oil; Interactions; LDL cholesterol; N 3 Fatty acids; Plant sterols; Plasma lipids; TAG

Indexed keywords

FISH OIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; N 3 LONG CHAIN POLYUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; STEROL DERIVATIVE; UNCLASSIFIED DRUG; YOGHURT;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPERLIPIDEMIA; INDIAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGE FACTORS; APOLIPOPROTEINS; CAPSULES; ENERGY INTAKE; FATTY ACIDS, OMEGA-3; FEMALE; FISH OILS; FOOD HABITS; HUMANS; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIAS; INDIA; LIFE STYLE; LIPIDS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PHYTOSTEROLS; REPRODUCIBILITY OF RESULTS;

EID: 70349402792     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114509297170     Document Type: Article

References (52)

1. Reddy KS, Shah B, Varghese C, et al. (2005) Responding to the threat of chronic diseases in India. Lancet 366, 1744-1749.
2. Goyal A & Yusuf S (2006) The burden of cardiovascular disease in the Indian subcontinent. Indian J Med Res 124, 235-244.
3. Reddy KS (2007) India wakes up to the threat of cardiovascular diseases. J Am Coll Cardiol 50, 1370-1372.
4. Rader DJ (2005) Novel approaches to the treatment of dyslipidemia. Arterioscler Thromb Vasc Biol 25, 480-481.
5. Joshi P, Islam S, Pais P, et al. (2007) Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. JAMA 297, 286-294.
6. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285, 2486-2497.
7. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106, 3143-3421.
8. Lichtenstein AH, Appel LJ, Brands M, et al. (2006) Summary of American Heart Association Diet and Lifestyle Recommendations Revision. Arterioscler Thromb Vasc Biol 26, 2186-2191.
9. International Atherosclerosis Society Executive Board (2003) International Atherosclerosis Society Harmonized Clinical Guidelines on Prevention of Atherosclerotic Vascular Disease. Full Report. http://www.athero.org/guidelines.asp
10. Katan MB, Grundy SM, Jones P, et al. (2003) Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc 78, 965-978.
11. Noakes M, Clifton PM, Doornbos AM, et al. (2005) Plant sterol ester-enriched milk and yoghurt effectively reduce serum cholesterol in modestly hypercholesterolemic subjects. Eur J Clin Nutr 44, 214-222.
12. Korpela R, Tuomilehto J, Hogstrom P, et al. (2006) Safety aspects and cholesterol-lowering efficacy of low fat dairy products containing plant sterols. Eur J Clin Nutr 60, 633-642.
13. Devaraj S, Autret BC & Jialal I (2006) Reduced-calorie orange juice beverage with plant sterols lowers C-reactive protein concentrations and improves the lipid profile in human volunteers. Am J Clin Nutr 84, 756-761.
14. Seppo L, Jauhiainen T, Nevala R, et al. (2007) Plant stanol esters in low-fat milk products lower serum total and LDL cholesterol. Eur J Clin Nutr 46, 111-117.
15. Plana N, Nicolle C, Ferre R, et al. (2008) Plant sterol-enriched fermented milk enhances the attainment of LDL-cholesterol goal in hypercholesterolemic subjects. Eur J Clin Nutr 47, 32-39.
16. Hyun YJ, Kim OY, Kang JB, et al. (2005) Plant stanol esters in low-fat yogurt reduces total and low-density lipoprotein cholesterol and low-density lipoprotein oxidation in normocholesterolemic and mildly hypercholesterolemic subjects. Nutr Res 25, 743-753.
17. Balk EM, Lichtenstein AH, Chung M, et al. (2006) Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk, a systematic review. Atherosclerosis 189, 19-30. (Pubitemid 44468073)
18. Robinson JG & Stone NJ (2006) Anti-atherosclerotic and antithrombotic effects of omega-3 fatty acids. Am J Cardiol 98, 39i-49i.
19. Kris-Etherton PM, Harris WS & Appel LJ (2003) Fish consumption, fish oil, omega-3 fatty acids and CVD. Arterioscler Thromb Vasc Biol 23, 20-30.
20. Naumann E, Plat J, Kester AM, et al. (2008) The baseline serum lipoprotein profile is related to plant stanol induced changes in serum lipoprotein cholesterol and triacylglycerol concentrations. J Am Coll Nutr 27, 117-126.
21. Demonty I, Chan Y, Pelled D, et al. (2006) Fish-oil esters of plant sterols improve the lipid profile of dyslipidemic subjects more than do fish-oil or sunflower oil esters of plant sterols. Am J Clin Nutr 84, 1534-1542.
22. Jones PJH, Demonty I, Chan YM, et al. (2007) Fish-oil esters of plant sterols differ from vegetable-oil sterol esters in triglycerides lowering, carotenoid bioavailability and impact on plasminogen activator inhibitor-1 (PAI-1) concentrations in hypercholesterolemic subjects. Lipids Health Dis 6, 28.
23. AbuMweis SS, Vanstone CA, Ebine N, et al. (2006) Intake of a single morning dose of standard and novel plant sterol preparations for 4 weeks does not dramatically affect plasma lipid concentrations in humans. J Nutr 136, 1012-1016.
24. Micallef MA & Garg ML (2008) The lipid-lowering effects of phytosterols and (n-3) polyunsaturated fatty acids are synergistic and complementary in hyperlipidemic men and women. J Nutr 138, 1086-1090.
25. Ainsworth B, Haskell W, Whit M, et al. (2000) Compendium of physical activities, an update of activity codes and MET intensities-measurement of moderate physical activity. Med Sci Sports Exerc 32, S498-S516.
26. Singh Y, Lakshmy R, Gupta R, et al. (2008) A rapid 3% polyacrylamide slab gel electrophoresis method for high throughput screening for LDL phenotype. Lipids Health Dis 7, 47.
27. Heritier SR, Gebski VJ & Keech AC (2003) Inclusion of patients in clinical trial analysis, the intention-to-treat principle. Med J Aust 179, 438-440.
28. Pocock SJ (1983) Further aspects of data analysis. In Clinical Trials. A Practical Approach, 2008 ed., pp. 211-233 [SJ Pocock, editor]. Chichester, UK: John Wiley & Sons Ltd.
29. Pocock SJ, Assmann SE, Enos LE, et al. (2002) Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: Current practice and problems. Stat Med 21, 2917-2930.
30. Senn S (2007) Baselines and covariate information. In Statistical Issues in Drug Development, 2nd ed., pp. 97-112 [S Senn, editor]. Chichester, UK: John Wiley & Sons Ltd.
31. Vickers AJ (2001) The use of percentage change from baseline as an outcome in a controlled trial is statistically inefficient: A simulation study. BMC Med Res Methodol 1, 6.
32. Salo P & Wester I (2005) Low-fat formulations of plant stanols and sterols. Am J Cardiol 96, 51D-54D.
33. Doornbos AM, Meynen EM, Duchateau GS, et al. (2006) Intake occasion affects the serum cholesterol lowering of a plant sterolenriched single-dose yoghurt drink in mildly hypercholesterolaemic subjects. Eur J Clin Nutr 60, 325-333.
34. Gylling H & Miettinen TA (1994) Serum cholesterol and cholesterol and lipoprotein metabolism in hypercholesterolaemic NIDDM patients before and during sitostanol ester-margarine treatment. Diabetologia 37, 773-780.
35. Gylling H & Miettinen TA (1996) Effects of inhibiting cholesterol absorption and synthesis on cholesterol and lipoprotein metabolism in hypercholesterolemic non-insulin-dependent diabetic men. J Lipid Res 37, 1776-1785.
36. Lau VW, Journoud M & Jones PJ (2005) Plant sterols are efficacious in lowering plasma LDL and non-HDL cholesterol in hypercholesterolemic type 2 diabetic and non-diabetic persons. Am J Clin Nutr 81, 1351-1358.
37. Lee YM, Haastert B, Scherbaum W, et al. (2003) A phytosterolenriched spread improves the lipid profile of subjects with type 2 diabetes mellitus: A randomized controlled trial under freeliving conditions. Eur J Clin Nutr 42, 111-117.
38. Hallikainen M, Lyyra-Laitinen T, Laitinen T, et al. (2008) Effects of plant stanol esters on serum cholesterol concentrations, relative markers of cholesterol metabolism and endothelial function in type 1 diabetes. Atherosclerosis 199, 432-439.
39. Plat J, Brufau G, Dasselaar M, et al. (2006) A stanol yogurt drink alone or combined with a low-dose OTC statin lowers non-HDL-C, but also lowers TAGs and elevated HDL-C in metabolic syndrome patients. Atherosclerosis Suppl 7, 452.
40. Plat J, Brufau G, de Jong NA, et al. (2007) Plant stanol esters not only lower LDL cholesterol, but also triacylglycerol levels; a new application in CHD lowering risk strategies for metabolic syndrome patients. Ann Nutr Metab 51, Suppl. 1, 276, P494.
41. Anonymous (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction, results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. The GISSI Prevenzione Group. Lancet 354, 447-455, erratum 357, 642.
42. Christiansen LI, Lähteenmäki PA, Mannelin MR, et al. (2001) Cholesterol-lowering effects of spreads enriched with microcrystalline plant sterols in hypercholesterolemic subjects. Eur J Clin Nutr 40, 66-73.
43. Hendriks HJ, Brink EJ, Meijer GW, et al. (2003) Safety of longterm consumption of plant sterol esters-enriched spread. Eur J Clin Nutr 57, 681-692.
44. Jones PJ, Raeini-Sarjaz M, Ntanios FY, et al. (2000) Modulation of plasma lipid levels and cholesterol kinetics by phytosterol versus phytostanol esters. J Lipid Res 41, 697-705.
45. Clifton PM, Mano M, Duchateau GS, et al. (2008) Doseresponse effects of different plant sterol sources in fat spreads on serum lipids and C-reactive protein and on the kinetic behavior of serum plant sterols. Eur J Clin Nutr 62, 968-977.
46. Hendriks HF, Weststrate JA, van Vliet T, et al. (1999) Spreads enriched with three different levels of vegetable oil sterols and the degree of cholesterol lowering in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr 53, 319-327.
47. Vanstone CA, Raeini-Sarjaz M, Parsons WE, et al. (2002) Unesterified plant sterols and stanols lower LDL-cholesterol concentrations equivalently in hypercholesterolemic persons. Am J Clin Nutr 76, 1272-1278.
48. Yoshida M, Vanstone CA, Parsons WD, et al. (2006) Effect of plant sterols and glucomannan on lipids in individuals with and without type II diabetes. Eur J Clin Nutr 60, 529-537.
49. Ravi GR, Pradeepa R & Mohan V (2004) Hypertriglyceridemia and coronary artery disease-an update. Indian Heart J 56, 21-26.
50. Sawant AM, Shetty D, Mankeshwar R, et al. (2008) Prevalence of dyslipidemia in young adult Indian population. J Assoc Physicans India 56, 99-102.
51. Rastogi T, Reddy KS, Vaz M, et al. (2004) Diet and risk of ischemic heart disease in India. Am J Clin Nutr 79, 582-592.
52. Reddy KS & Katan MB (2004) Diet, nutrition and the prevention of hypertension and cardiovascular diseases. Public Health Nutr 7, 167-186.